StockOtters
StockOttersSupply Chain Map
GC Biopharma Corp. logo

GC Biopharma Corp.

006280.KS

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
1,260
Cost of Revenue
898
Gross Profit
361
Gross Margin
28.7%
Operating Income
24
Operating Margin
1.9%
Net Income
-20
Net Margin
-1.6%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
60
EBITDA Margin
4.8%

2023

12/31/2023

Revenue
1,220
Cost of Revenue
857
Gross Profit
363
Gross Margin
29.8%
Operating Income
26
Operating Margin
2.1%
Net Income
-20
Net Margin
-1.6%
EPS (Basic)
$-2.00
EPS (Diluted)
$-2.00
EBITDA
82
EBITDA Margin
6.8%

2022

12/31/2022

Revenue
1,283
Cost of Revenue
847
Gross Profit
436
Gross Margin
34.0%
Operating Income
61
Operating Margin
4.7%
Net Income
49
Net Margin
3.8%
EPS (Basic)
$4.00
EPS (Diluted)
$4.00
EBITDA
140
EBITDA Margin
10.9%

2021

12/31/2021

Revenue
1,153
Cost of Revenue
763
Gross Profit
390
Gross Margin
33.9%
Operating Income
55
Operating Margin
4.8%
Net Income
92
Net Margin
8.0%
EPS (Basic)
$8.00
EPS (Diluted)
$8.00
EBITDA
119
EBITDA Margin
10.3%

2020

12/31/2020

Revenue
1,128
Cost of Revenue
798
Gross Profit
330
Gross Margin
29.3%
Operating Income
38
Operating Margin
3.3%
Net Income
61
Net Margin
5.4%
EPS (Basic)
$5.00
EPS (Diluted)
$5.00
EBITDA
127
EBITDA Margin
11.2%